China Galaxy Securities Co Ltd Class A (601881)
Shanghai Stock Exchange · China · prices in CNY · close of 19 Oct 2026
Key indicators
| Last close | CNY 11.78 |
|---|---|
| 52-week range | 11.35 – 18.46 |
| Return, 1 month / 3 months | −4.0% / −8.3% |
| Return, 1 year / 3 years | −30.9% / −2.0% |
| Trend | Below its 200-day average |
| RSI (14) | 45 |
| Volatility (1 year) | 24.3% |
| Worst drawdown (1 year) | -37.4% |
| Average daily value traded | 319.76M CNY |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
China Galaxy Securities is a securities firm based in Beijing that serves individual investors and institutional clients across China. It offers brokerage services for trading in stocks, bonds and funds, along with investment banking work such as underwriting and sponsorship, asset management products, and margin financing and securities lending. The company also runs research and advisory operations, and it serves corporate and government clients through its investment banking and fixed income businesses.
The shares are listed on the Shanghai Stock Exchange in China under the code 601881, and the price on this page is in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
China Galaxy Securities Co Ltd Class A (601881) trades on the Shanghai Stock Exchange in China. It last closed at CNY 11.78 on 19 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 680 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 30.9% and over the last three months it fell 8.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -11.3% | ||
| From 52-week high | -35.3% | ||
| Momentum | 39 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.3% | ||
| 6-month return | -9.5% | ||
| 12-month return, skipping the last month | -28.0% | ||
| Stability (higher is calmer) | 80 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.4% | ||
| Liquidity | 73 · Strong | Trades actively. | |
| Average daily value traded | 319.76M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +0.6% |
|---|---|
| 1 month | −4.0% |
| 3 months | −8.3% |
| 6 months | −9.5% |
| 1 year | −30.9% |
| 3 years | −2.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 12.11 / 13.29 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.20 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Jul 2023 | CNY 0.2253 |
| 15 Jul 2022 | CNY 0.3100 |
| 15 Jul 2021 | CNY 0.2200 |
| 15 Jul 2020 | CNY 0.1600 |
| 10 Jun 2019 | CNY 0.0900 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.